These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21439109)

  • 1. No medication without representation? Generalizing from antidepressant clinical efficacy trials to clinical practice.
    Anderson IM
    Psychol Med; 2011 Jul; 41(7):1349-51. PubMed ID: 21439109
    [No Abstract]   [Full Text] [Related]  

  • 2. Ideal and Reality: The Gap Between Evidence Derived From Randomized Controlled Trial-Based Meta-analysis and Real-World Clinical Practice in Antidepressant Strategy for Depression.
    Wang H; Wang L; Xiao J
    J Clin Psychopharmacol; 2020; 40(4):428-429. PubMed ID: 32639301
    [No Abstract]   [Full Text] [Related]  

  • 3. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.
    Seemüller F; Möller HJ; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Schennach-Wolff R; Henkel V; Riedel M
    J Clin Psychiatry; 2010 Nov; 71(11):1425-33. PubMed ID: 20816028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The search for improved antidepressant strategies: is bigger better?
    Coryell W
    Am J Psychiatry; 2011 Jul; 168(7):664-6. PubMed ID: 21724669
    [No Abstract]   [Full Text] [Related]  

  • 5. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
    J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial?
    Keitner GI; Posternak MA; Ryan CE
    J Clin Psychiatry; 2003 Sep; 64(9):1091-3. PubMed ID: 14628985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More on placebo response.
    Allan Mattes J
    J Clin Psychiatry; 2007 Dec; 68(12):1984; author reply 1984-5. PubMed ID: 18162034
    [No Abstract]   [Full Text] [Related]  

  • 8. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
    Zimmerman M; Mattia JI; Posternak MA
    Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
    Mallinckrodt CH; Prucka WR
    Clin Pharmacol Ther; 2010 Nov; 88(5):592-4. PubMed ID: 20959845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prescription of antidepressants shows correction of inadequate duration of treatment of depression.
    Reid I; Cameron I; MacGillivray S
    BMJ; 2014 Jan; 348():g228. PubMed ID: 24448343
    [No Abstract]   [Full Text] [Related]  

  • 12. Caught in the act? Prevalence, predictors, and consequences of physician detection of unannounced standardized patients.
    Franz CE; Epstein R; Miller KN; Brown A; Song J; Feldman M; Franks P; Kelly-Reif S; Kravitz RL
    Health Serv Res; 2006 Dec; 41(6):2290-302. PubMed ID: 17116121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
    Schultz J; Joish V
    Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice.
    van der Lem R; van der Wee NJ; van Veen T; Zitman FG
    Psychol Med; 2011 Jul; 41(7):1353-63. PubMed ID: 21078225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patient requests for antidepressants enhance or hinder physicians' evaluation of depression? A randomized controlled trial.
    Feldman MD; Franks P; Epstein RM; Franz CE; Kravitz RL
    Med Care; 2006 Dec; 44(12):1107-13. PubMed ID: 17122715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
    Cassidy F
    Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
    Levkovitz Y; Tedeschini E; Papakostas GI
    J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
    Kravitz RL; Epstein RM; Feldman MD; Franz CE; Azari R; Wilkes MS; Hinton L; Franks P
    JAMA; 2005 Apr; 293(16):1995-2002. PubMed ID: 15855433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Have Treatment Studies of Depression Become Even Less Generalizable? Applying the Inclusion and Exclusion Criteria in Placebo-Controlled Antidepressant Efficacy Trials Published over 20 Years to a Clinical Sample.
    Zimmerman M; Balling C; Chelminski I; Dalrymple K
    Psychother Psychosom; 2019; 88(3):165-170. PubMed ID: 31096246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.